Skip to content

November News Round Up

๐๐จ๐ฏ๐ž๐ฆ๐›๐ž๐ซ ๐๐ž๐ฐ๐ฌ ๐‘๐จ๐ฎ๐ง๐ ๐”๐ฉ

๐Ÿ•ถ ๐“๐ก๐ž๐ฅ๐ข๐จ๐ฌ ๐ˆ๐ง๐ฏ๐ž๐ฌ๐ญ๐ฌ ๐ข๐ง ๐Œ๐˜๐Š๐ˆ๐“๐€
Berlin-based eyewear brand MYKITA and Thรฉlios, the LVMH Groupโ€™s eyewear division, announced that Thรฉlios will make a minority investment in MYKITA, pending regulatory approval. MYKITA will retain full independence in design, production, and distribution.

๐Ÿ‘ ๐…๐ƒ๐€ ๐‚๐ฅ๐ž๐š๐ซ๐ฌ ๐‹๐ฎ๐ฆ๐ข๐“๐ก๐ž๐ซ๐šโ€™๐ฌ ๐•๐š๐ฅ๐ž๐๐š ๐“๐ก๐ž๐ซ๐š๐ฉ๐ฒ ๐Ÿ๐จ๐ซ ๐ƒ๐ซ๐ฒ ๐€๐Œ๐ƒ
LumiThera, Inc.'s Valedaยฎ Light Delivery System has gained FDA approval, becoming the first authorized therapy for dry age-related macular degeneration (AMD). This non-invasive treatment, using Photobiomodulation, has shown to improve visual acuity and may slow disease progression, offering new hope for early intervention in a leading cause of vision loss.

๐Ÿ‘ฉโ€โš•๏ธ ๐ˆ๐ฌ ๐“๐ก๐ž ๐…๐ฎ๐ญ๐ฎ๐ซ๐ž ๐จ๐Ÿ ๐Ž๐ฉ๐ญ๐จ๐ฆ๐ž๐ญ๐ซ๐ฒ ๐…๐ž๐ฆ๐š๐ฅ๐ž?
A major shift is happening in optometry, with women now making up the majority of incoming optometry studentsโ€”a trend that has been building for years. This demographic change reflects the growing presence of women in the profession and its potential to shape the industry's future.

Catch the full analysis and insights in our recent article linked in the comments โฌ‡๏ธ

๐Ÿ’Š ๐ˆ๐ฆ๐ฉ๐š๐œ๐ญ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐”๐’ ๐„๐ฅ๐ž๐œ๐ญ๐ข๐จ๐ง๐ฌ ๐จ๐ง ๐ญ๐ก๐ž ๐…๐ƒ๐€ ๐š๐ง๐ ๐„๐ฒ๐ž๐œ๐š๐ซ๐ž ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ
The election of President Trump and potential healthcare reforms led by Robert F. Kennedy Jr. signal major changes for the eyecare industry. The administrationโ€™s focus on deregulation could streamline FDA approval processes, accelerating innovation and increasing competition, while Kennedyโ€™s proposed caps on drug pricing and a ban on pharmaceutical advertising may reshape the market.
Post-election, healthcare job postings rose 18%, with regulatory and sales roles surging in response to anticipated policy shifts. Vision Executives has already seen a spike in US-based roles.

Explore the full news story over at James Pickeringโ€™s page along with our vacancy page for these emerging opportunities!

๐Ÿ‘€ ๐‘๐ž๐๐ฎ๐œ๐ข๐ง๐  ๐†๐ ๐’๐ญ๐ซ๐š๐ข๐ง & ๐ˆ๐ฆ๐ฉ๐ซ๐จ๐ฏ๐ข๐ง๐  ๐„๐ฒ๐ž ๐‚๐š๐ซ๐ž ๐€๐œ๐œ๐ž๐ฌ๐ฌ
New data from the Royal College of General Practitioners shows GPs in less affluent areas now manage an average of 2451 patients, significantly more than their counterparts in affluent regions. This growing disparity highlights the strain on primary care.

The AOP emphasizes the potential of optometrists to ease this burden by handling eye-related concerns. Chief executive Adam Sampson calls for expanded optometrist roles to improve care access and relieve pressure on overstretched GPs.